{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:59:37Z","timestamp":1791381577017,"version":"4.3.3"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.intimp.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T15:03:45Z","timestamp":1453388625000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?"],"prefix":"10.1016","volume":"32","author":[{"given":"Behshad","family":"Mofid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khaksari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Shahrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouzar","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Karamouzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ahmadinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Maiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Khazaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.01.015_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001199-200307000-00003","article-title":"Diffuse axonal injury in head trauma","volume":"18","author":"Smith","year":"2003","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.intimp.2016.01.015_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0079-6123(06)61009-1","article-title":"Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies","volume":"161","author":"Bramlett","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005373-200202000-00021","article-title":"Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients","volume":"52","author":"Woiciechowsky","year":"2002","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.intimp.2016.01.015_bb0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(01)02013-3","article-title":"Interleukin-6 promotes post-traumatic healing in the central nervous system","volume":"896","author":"Swartz","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tips.2010.09.005","article-title":"Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies","volume":"31","author":"Loane","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2016.01.015_bb0030","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/aps.2013.160","article-title":"The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2016.01.015_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yhbeh.2012.05.004","article-title":"A clinical\/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?","volume":"63","author":"Stein","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.intimp.2016.01.015_bb0040","first-page":"13","article-title":"Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries","volume":"6","author":"Stein","year":"2003","journal-title":"Dev. Neurorehabil."},{"key":"10.1016\/j.intimp.2016.01.015_bb0045","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.clineuro.2013.06.013","article-title":"Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma","volume":"115","author":"Shakeri","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.intimp.2016.01.015_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.annemergmed.2006.07.932","article-title":"ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury","volume":"49","author":"Wright","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.intimp.2016.01.015_bb0055","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/cc6887","article-title":"Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial","volume":"12","author":"Xiao","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2016.01.015_bb0060","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","article-title":"A clinical trial of progesterone for severe traumatic brain injury","volume":"371","author":"Skolnick","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2016.01.015_bb0065","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2016.01.015_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1212\/01.WNL.0000049931.77887.7F","article-title":"Protein S-100b serum levels in trauma-induced brain death","volume":"60","author":"Dimopoulou","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2016.01.015_bb0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood\u2013brain barrier dysfunction in patients with traumatic brain injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0080","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/neu.2004.21.1553","article-title":"GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome","volume":"21","author":"Pelinka","year":"2004","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/089771501300227297","article-title":"S-100 \u03b2 reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury","volume":"18","author":"Pleines","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B's double life: intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/02688699944195","article-title":"Serum markers of brain damage and outcome prediction in patients after severe head injury","volume":"13","author":"A.","year":"1999","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.intimp.2016.01.015_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00701-007-1489-2","article-title":"Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury","volume":"150","author":"Nyl\u00e9n","year":"2008","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.intimp.2016.01.015_bb0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.resuscitation.2008.11.021","article-title":"Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point","volume":"80","author":"Rainey","year":"2009","journal-title":"Resuscitation"},{"key":"10.1016\/j.intimp.2016.01.015_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(01)02299-6","article-title":"4-Hydroxynonenal impairs the permeability of an in vitro rat blood\u2013brain barrier","volume":"314","author":"Mertsch","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2016.01.015_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13311-011-0085-6","article-title":"Antioxidant strategies in neurocritical care","volume":"9","author":"Hanafy","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.intimp.2016.01.015_bb0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10715760902751902","article-title":"Involvement of ROS in BBB dysfunction","volume":"43","author":"Pun","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/neu.2005.22.3","article-title":"Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis","volume":"22","author":"Hillered","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2010.07.038","article-title":"Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress","volume":"1354","author":"Ji","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3171\/jns.1996.85.3.0476","article-title":"Blood\u2013brain barrier breach following cortical contusion in the rat","volume":"85","author":"Baldwin","year":"1996","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.intimp.2016.01.015_bb0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neulet.2015.06.023","article-title":"Progesterone alleviates acute brain injury via reducing apoptosis and oxidative stress in a rat experimental subarachnoid hemorrhage model","volume":"600","author":"Cai","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2016.01.015_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02815156","article-title":"Progesterone protects against lipid peroxidation following traumatic brain injury in rats","volume":"31","author":"Roof","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2007.06.001","article-title":"Progesterone: therapeutic opportunities for neuroprotection and myelin repair","volume":"116","author":"Schumacher","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2016.01.015_bb0155","first-page":"219","article-title":"Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury","volume":"25","author":"Shahrokhi","year":"2012","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2016.01.015_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2003.09.023","article-title":"Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex","volume":"123","author":"Djebaili","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2016.01.015_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2005.05.004","article-title":"Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury","volume":"1049","author":"Pettus","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2007.08.045","article-title":"Neurosteroids reduce inflammation after TBI through CD55 induction","volume":"425","author":"VanLandingham","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2016.01.015_bb0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1139\/Y09-126","article-title":"Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury","volume":"88","author":"Shahrokhi","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1139\/Y10-103","article-title":"The role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury","volume":"89","author":"Khaksari","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/neu.2010.1686","article-title":"Time- and dose-dependent neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury","volume":"30","author":"Sarkaki","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00381-009-1009-1","article-title":"Clinical applications of biomarkers in pediatric traumatic brain injury","volume":"26","author":"Sandler","year":"2010","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.intimp.2016.01.015_bb0195","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2010.03.004","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Moher","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0200","first-page":"1","article-title":"2: In vivo evolution of microvascular inflammation after traumatic brain injury: an intravital microscopy study","volume":"39","author":"Li","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2016.01.015_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00063110-199606000-00010","article-title":"Guidelines for the management of severe head injury","volume":"3","author":"Bullock","year":"1996","journal-title":"Eur. J. Emerg. Med."},{"key":"10.1016\/j.intimp.2016.01.015_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/neu.1998.15.573","article-title":"Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use","volume":"15","author":"Wilson","year":"1998","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0215","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.apmr.2013.07.005","article-title":"Long-term disability and survival in traumatic brain injury: results from the National Institute on Disability and Rehabilitation research model systems","volume":"94","author":"Brooks","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.intimp.2016.01.015_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2016.01.015_bb0225","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","article-title":"Effect of intravenous corticosteroids on death within 14days in 10,008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial","volume":"364","author":"Roberts","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2016.01.015_bb0230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/neu.2008.0586","article-title":"Classification of traumatic brain injury for targeted therapies","volume":"25","author":"Saatman","year":"2008","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00701-005-0674-4","article-title":"All roads lead to disconnection?\u2014Traumatic axonal injury revisited","volume":"148","author":"B\u00fcki","year":"2006","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.intimp.2016.01.015_bb0240","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/B978-0-444-52892-6.00028-3","article-title":"Recent developments in clinical trials for the treatment of traumatic brain injury","volume":"127","author":"Stein","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(06)70630-5","article-title":"Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial","volume":"6","author":"Temkin","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0250","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jama.2013.169158","article-title":"Traumatic brain injury: an international knowledge-based approach","volume":"310","author":"Manley","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2016.01.015_bb0255","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/089771502753754037","article-title":"Clinical trials in head injury","volume":"19","author":"Narayan","year":"2002","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0260","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1089\/neu.2011.1911","article-title":"The effect of progesterone dose on gene expression after traumatic brain injury","volume":"28","author":"Anderson","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0265","first-page":"425","article-title":"Progesterone treatment attenuates brain edema following contusion injury in male and female rats","volume":"4","author":"Roof","year":"1992","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.intimp.2016.01.015_bb0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0306-4522(91)90377-Z","article-title":"Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells","volume":"42","author":"Smith","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2016.01.015_bb0275","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/neu.2008.0738","article-title":"Validation of serum markers for blood\u2013brain barrier disruption in traumatic brain injury","volume":"26","author":"Blyth","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0280","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.brainresrev.2007.06.012","article-title":"Progesterone exerts neuroprotective effects after brain injury","volume":"57","author":"Stein","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.intimp.2016.01.015_bb0285","first-page":"637","article-title":"Circulation and energy metabolism of the brain","volume":"6","author":"Clarke","year":"1999","journal-title":"Basic Neurochem. Mol. Cell. Med. Asp."},{"key":"10.1016\/j.intimp.2016.01.015_bb0290","first-page":"949","article-title":"Oxidative damage after severe head injury and its relationship to neurological outcome","volume":"51","author":"Paolin","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.intimp.2016.01.015_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jocn.2004.12.002","article-title":"Increased xanthine oxidase activity after traumatic brain injury in rats","volume":"12","author":"Solaroglu","year":"2005","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.intimp.2016.01.015_bb0300","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/neu.1998.15.789","article-title":"Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function","volume":"15","author":"Sullivan","year":"1998","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0305","first-page":"57","article-title":"Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring","volume":"22","author":"Herrmann","year":"2004","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.intimp.2016.01.015_bb0310","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0079-6123(06)61022-4","article-title":"The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications","volume":"161","author":"Kleindienst","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0315","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jss.2007.05.029","article-title":"Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats","volume":"147","author":"Chen","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0320","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.expneurol.2005.01.009","article-title":"Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia","volume":"193","author":"Gibson","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/neu.2008.0719","article-title":"Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery","volume":"26","author":"Helmy","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2016.01.015_bb0330","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1179\/016164107X204738","article-title":"Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression","volume":"29","author":"Lu","year":"2007","journal-title":"Neurol. Res."},{"key":"10.1016\/j.intimp.2016.01.015_bb0335","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1139\/cjpp-2012-0359","article-title":"The effect of female sexual hormones on the intestinal and serum cytokine response after traumatic brain injury: different roles for estrogen receptor subtypes","volume":"91","author":"Khaksari","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0340","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.injury.2007.10.003","article-title":"Systemic inflammation after trauma","volume":"38","author":"Lenz","year":"2007","journal-title":"Injury"},{"key":"10.1016\/j.intimp.2016.01.015_bb0345","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/IAI.61.4.1496-1499.1993","article-title":"Protective role of interleukin 6 in the lipopolysaccharide\u2013galactosamine septic shock model","volume":"61","author":"Barton","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2016.01.015_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejpn.2007.07.016","article-title":"Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children","volume":"12","author":"Chiaretti","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.intimp.2016.01.015_bb0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1096\/fj.03-0323fje","article-title":"Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-\u03baB and AP-1","volume":"18","author":"Beni","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2016.01.015_bb0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2005.03.035","article-title":"Free radicals as triggers of brain edema formation after stroke","volume":"39","author":"Heo","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2016.01.015_bb0365","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MCC.0b013e3282f57564","article-title":"Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making","volume":"14","author":"Kochanek","year":"2008","journal-title":"Curr. Opin. Crit. Care"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T03:04:20Z","timestamp":1600052660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":73,"alternative-id":["S1567576916300145"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.015","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}